Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CLO test results

16 Sep 2009 07:30

RNS Number : 1252Z
T2 Income Fund Limited
16 September 2009
 

T2 Income Fund Limited ("T2" or the "Company")

Monthly CLO Test Results

The Company announces the test results as of 2 September 2009 pursuant to the indenture of the Company's subsidiary, T2 Income Fund CLO I Ltd (the "CLO"). The report summarising the results of those tests can be found at the link below:

http://www.rns-pdf.londonstockexchange.com/rns/1252Z_-2009-9-15.pdf

With respect to the various tests required under the CLO indenture, on 14 September 2009, the CLO passed all collateral coverage tests and all of the loans held within the CLO continue to pay the interest due. 

It should be noted that the implications of failing the collateral coverage tests are very complicated, and the consequences could include interest diversion, principal repayment, or limitations on reinvestment of available cash balances. 

Distinct from the collateral coverage tests are the percentage limitation tests. The consequence of failing these percentage limitation tests is simply that each new investment made by the CLO must "maintain or improve" the test result.

The CLO failed four portfolio percentage limitation tests, two of which relate to limitations on loans rated CCC+/Caa1 and lower by S&P and Moody's, respectively, one related to the highest single obligor for non-senior secured loans and one related to the minimum percentage of senior secured loans required to be outstanding.

The failure of the senior secured loan minimum percentage was due to the amount of cash held within the CLO ($32.1 million); cash is excluded when calculating the percentage of senior secured loans. The Company believes that the substantial cash balance provides an opportunity to acquire better-rated securities at discounts to their par value, which should help to improve the quality of the portfolio as well as improve the CLO's collateral test coverage ratios under a variety of scenarios. As cash is invested in new senior secured loans, this failure should be cured automatically. Although no new investments rated CCC+/Caa1 or lower have been made by the manager for some time, the failure of CCC+/Caa1 percentage limitations tests occurred due to historic and ongoing downgrades of companies by S&P and Moody's. The manager continues to evaluate opportunities to reduce the amount of these loans in situations where a sale could be achieved without incurring substantial principal losses.

The failure of the highest single obligor for non-senior secured ("second lien") loans percentage was due to the sale of certain loans at the CLO's option in August , due to credit concerns, at a realized loss, which reduced the aggregate collateral balance from approximately $303 million in July 2009 to $297 million in August 2009. Since there is a single non-senior secured loan of $9.0 million currently outstanding, the 3.0% maximum limit percentage was violated. However, this specific test is a "maintain and improve" covenant and thus does result in interest diversion or principal paydown.

These covenant violations described above do not have a material impact on the CLO's ability to invest in new loans, and all of the loans held within the CLO continue to pay the interest due.

The next payment test date is 2 October 2009. While we continue to monitor the situation closely, we currently have only limited visibility with respect to which of the CLO tests may or may not be met on that date or other future dates, and whether any further principal paydowns or interest diversions may occur and, if so, the magnitude of those paydowns or diversions.  

While the current month's test results are not controlling as to the 2 October 2009 payment test, it may be worth noting that, had this been a payment test, there would not have been an interest diversion.

As described in previous press releases, the CLO indenture contains a variety of covenants, compliance with which could be made more difficult or impossible should credit markets deteriorate or the loans held by the CLO fail to make expected payments or otherwise not perform.

Contacts:

Geoffrey MillerT2 Income Fund Limited+353 1 4433 466

Patrick ConroyT2 Income Fund Limited+1 203 983 5282

Philip SecrettNominated AdviserGrant Thornton UK LLP+44 (0) 20 7383 5100

Jos TrustedSinger Capital Markets Limited +44 (0) 20 3205 7622

Ed Gascoigne PeesFinancial Dynamics+44 (0) 20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFFFLASIELIA
Date   Source Headline
18th Sep 20137:00 amRNSAdditional Listing
2nd Sep 20137:00 amRNSInvestment in crowd-funding platform
16th Aug 20134:15 pmRNSHolding(s) in Company
25th Jul 20137:58 amRNSNAV and Trading Update
25th Jul 20137:58 amRNSDividend Declaration
16th Jul 20137:00 amRNSInvestment
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSAdditional Listing
10th Jun 201311:00 amRNSShare Dealing
6th Jun 20134:00 pmRNSDirector/PDMR Shareholding
24th May 20135:00 pmRNSDirector/PDMR Shareholding
22nd May 20138:00 amRNSDirector/PDMR Shareholding
17th May 20139:00 amRNSDirector/PDMR Shareholding
15th May 20138:20 amRNSDirector/PDMR Shareholding
14th May 20134:30 pmRNSDirector/PDMR Shareholding
13th May 20138:00 amRNSHolding(s) in Company
30th Apr 20134:00 pmRNSResult of AGM
25th Apr 20138:30 amRNSHolding(s) in Company
23rd Apr 20134:45 pmRNSDirector/PDMR Shareholding
22nd Apr 20133:15 pmRNSHolding(s) in Company
18th Apr 20138:15 amRNSDividend Declaration
18th Apr 20138:15 amRNSNAV Update and CLO Test Result
9th Apr 20135:30 pmRNSAnnual Report
3rd Apr 20137:00 amRNSFull Year Results 2012
28th Mar 20137:02 amRNSNotice of Preliminary Results
23rd Jan 20137:01 amRNSPlacing
23rd Jan 20137:00 amRNSNAV Update, dividend payment and CLO Test Results
18th Jan 20132:49 pmRNSDirector/PDMR Shareholding
19th Nov 20122:30 pmRNSHolding(s) in Company
14th Nov 201212:00 pmRNSHolding(s) in Company
13th Nov 20128:00 amRNSHolding(s) in Company
12th Nov 201212:30 pmRNSDirector/PDMR Shareholding
8th Nov 201212:45 pmRNSConfirmation of Final Consideration Payable
7th Nov 20127:00 amRNSAcquisition
29th Oct 20127:00 amRNSAnnouncement of Dividend
19th Oct 20127:00 amRNSNAV Update and Quarterly CLO Test Results
20th Sep 20127:00 amRNSHalf Year Results 2012 Replacement
18th Sep 20126:27 pmRNSDirector/PDMR Shareholding
14th Sep 20127:00 amRNSHalf Year Results 2012
19th Jul 20129:00 amRNSTrading Statement
17th Jul 20123:51 pmRNSHolding(s) in Company
30th Apr 20125:00 pmRNSResult of AGM
20th Apr 20129:30 amRNSQuarterly CLO Test Results
19th Apr 20125:00 pmRNSNAV Update and dividend
5th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:46 pmRNSDealing by Investment Manager
26th Mar 20127:00 amRNSFull Year Results 2011
13th Mar 20127:00 amRNSNotice of Results
12th Mar 20127:00 amRNSChange of Adviser
19th Jan 20124:50 pmRNSNAV Update and Dividend Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.